Skip to main content

Diabetes Conferences

Exciting and important news in the diabetes sphere from the biggest diabetes conferences around the world. 

What's new

EASD day 3 diabetes 2018

CGM data in people without diabetes, time-in-range and A1C benefits in large hybrid closed loop study, plus trial results studying Jardiance in type 1 as well as Lilly’s new GLP/GIP agonist therapy Continue Reading »

EASD day 2 diabetes

SGLT-1/2 therapy for type 1 diabetes, hybrid closed loop systems in teens and children, and the importance of glucose control as an outcome in addition to A1C! Continue Reading »

EASD 2018 diabetes

The most promising therapies in the pipeline, accuracy data on the FreeStyle Libre 2, and more Continue Reading »

12th annual forum diaTribe TCOYD 2018

The diaTribe Foundation and TCOYD hosted a panel discussion at the ADA 78th Scientific Sessions in Orlando, Florida; read about insights on how to improve diabetes care Continue Reading »

Musings Under the Moon 2018

Kelly Close and Adam Brown led two panels on next-generation diabetes at The diaTribe Foundation’s third annual gathering during ADA 2018; plus highlights from the “after hours” fireside chat on patient-centric innovation Continue Reading »

ADA 2018 diabetes news

U500 insulin delivery through Omnipod pump, comparing insulin secretion between Mediterranean and ketogenic meals, a head-to-head with Afrezza and NovoLog, Qtern combination therapy results, and more! Continue Reading »

ADA 2018 diabetes

Using time-in-range to assess risk for complications, Omnipod Horizon Closed Loop, Bihormonal closed loop (insulin + Pramlintide), SGLT-2 oral drug for type 1, and more! Continue Reading »

ADA 2018 conference highlights

Read about combo drug Xultophy, Toujeo vs. Tresiba, diabetes apps, the do-it-yourself community, FreeStyle Libre real-world data, and more! Continue Reading »